CYTOSAR® 500 mg


Powder for solution for injection
scheduling status
S4
registration number
T/26/47
What CYTOSAR® 500 mg contains
Cytarabine.
other ingredients
Powder (vial): Hydrochloric acid (pH adjustment) Sodium hydroxide (pH adjustment) Co‑packaged diluent: Water for injection Benzyl alcohol 0.9% m/v.
Therapeutic classification
L01BC01 Antineoplastic agents – Pyrimidine analogues (cytarabine).
© 2026 SAHPRA. ALL RIGHTS RESERVED